CTOs on the Move

Contego Medical

www.contegomedical.com

 
Contego Medical, founded in 2005, has developed a family of novel emboli protection devices. The main feature of each device is that the treatment portion (i.e., balloon or stent) is on the same catheter as the embolic protection device, thus coupling the two together. This device can act as an angioplasty balloon with an integrated emboli protection device. If a stent is mounted on the balloon, it can serve as a stent with an integrated emboli protection device. We know that embolization occurs with all angioplasty and stenting procedures. It is usually hard to predict which ones will result in clinical ...
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Contego Medical raised $22M on 01/13/2020

Similar Companies

Owens Healthcare

Owens Healthcare is a Redding, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bio Cybernetics International

Bio Cybernetics International is a La Verne, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Five Star Surgical

Five Star Surgical, Inc. is a New Bedford, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

VirtualScopics

To improve the lives of those impacted by disease and disability.   To provide accessible, accurate, and reliable analysis in a way that facilitates and adapts to our clients` needs to progress their clinical trials at the fastest possible pace.   While our technology makes us unique, it is our people who make us special. Our teams utilize creativity, flexibility and expertise to design personalized solutions to meet our customers` goals and objectives. But what truly sets us apart is the internal motivation of our employees and the pride they take in helping customers affect the lives of those in need.

Silk Road Medical

Silk Road Medical, Inc. is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. The TransCarotid Artery Revascularization (TCAR) Procedure is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. The ENROUTE® Transcarotid Neuroprotection and Stent System are the first and only products specifically designed and indicated for TCAR in high surgical risk patients that need carotid intervention.